Key Stakeholder Perspectives on Vaccination for Elderly Infectious Disease Prevention in the US

CHALLENGE

A global strategy consulting firm aimed to gather insights on the landscape for recommending a specific infectious disease vaccination among the elderly in the United States. The firm sought to understand the perceived burden of the disease within this demographic, the willingness of healthcare providers and key opinion leaders (KOLs) to recommend the vaccine across different age groups, and the necessary actions to encourage vaccine adoption among the elderly.

BTHT APPROACH

To address the client's objectives, BTHT team curated a diverse portfolio of experts who could provide deep insights into the US vaccination landscape, particularly focusing on the elderly population. The expert profiles included:

• C-level professionals from major private insurance firms, offering perspectives on coverage, reimbursement, and payer strategies.
• Former leaders from the Centers for Disease Control and Prevention (CDC), who could discuss public health guidelines and the broader impact of infectious diseases on the elderly.
• Infectious Diseases Physicians with direct clinical experience in treating elderly patients, providing valuable insights into the medical community's views and concerns.
• Former C-level executives and directors from leading pharmaceutical companies, who had experience in launching and marketing similar vaccines, thus offering strategic and operational insights.

Our team meticulously sourced and screened these experts, ensuring their expertise aligned with the project's specific needs. The experts were selected based on their knowledge of the infectious disease in question, their understanding of vaccine deployment strategies, and their experience in influencing healthcare policy and practice.

OUTCOME

The client gained a nuanced understanding of the infectious disease's perceived burden in the elderly population and identified key factors influencing healthcare professionals' willingness to recommend the vaccine. The insights gathered from these expert consultations provided a solid foundation for developing a targeted strategy to promote the vaccine's adoption. The discussions highlighted specific actions needed to enhance the vaccine's acceptance, including educational campaigns, addressing potential concerns, and strategic partnerships with payers and healthcare providers.